SAN RAFAEL, Calif., Feb. 24, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today ...
Heterocyclic insulin-like growth factor 1 receptor (IGF-1R; CD221) inhibitors potentially useful for...
On Tuesday, Amgen Inc (NASDAQ:AMGN) reported fourth-quarter sales of $9.10 billion, up 11% year-over...
Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cho...